AbCellera Biologics’ share price {$ABCL} had climbed about 31% by mid-morning Monday after the biotech shared positive data from a mid-stage hot flashes trial that surpassed Wall Street's expectations. The biotech’s NK3R (neurokinin 3 receptor)-targeting ...